UNH
UnitedHealth Group Incorporated
Healthcare · Healthcare Plans · United States · Stock
Score Breakdown
Scored for Dividend Income profile
Sub-scores are 0–20 each; Model Score is weighted by your selected investment goal. How it works →
Why Ranked Here
- Revenue growth was solid at +11.8%, but the simultaneous -16.3% decline in net income created a divergence that limited the growth score.
- Thin profitability margins and volatile quarterly earnings weighed on both the profitability and momentum factors, pulling the composite score below midpoint.
- The absence of any macro theme assignment meant no thematic score contribution, and the sharp FY2025 dividend per share decline tempered the dividend factor as well.
Why Not Higher
- The dramatic collapse in 2025Q4 net income to $10,000,000 and operating income to $380,000,000, combined with persistently thin margins, prevented higher profitability and momentum scores.
- The sharp drop in dividends per share from $8.18 in FY2024 to $2.10 in FY2025 undermined what had been a multi-year dividend growth story.
Data Confidence
10 / 10
Very High — full data coverage
Why This Score
Grounded in figures from this company's SEC EDGAR filings — not a restatement of the score itself.
Revenue grew from FY2024's $400,278,000,000 to FY2025's $447,567,000,000, a gain of +11.8%. However, net income fell from FY2024's $14,405,000,000 to FY2025's $12,056,000,000 (-16.3%), and diluted EPS declined from FY2024's $15.51 to FY2025's $13.23 (-14.7%).
The model rewarded the solid top-line expansion but penalized the meaningful contraction in bottom-line profitability, resulting in a below-midpoint score that reflects the divergence between revenue growth and earnings deterioration.
In FY2025, UnitedHealth Group reported a net margin of 2.7%, an operating margin of 4.2%, and a return on assets of 3.9%, all of which are thin by broad market standards.
The model assigned a low score because these margin and return figures indicate that a very small share of revenue and assets translates into profit, which is characteristic of managed-care economics but still constrains the profitability rating.
In FY2025, UnitedHealth Group carried a debt-to-equity ratio of 0.78 and an interest coverage ratio of 4.7, against a total asset base of $309,581,000,000.
The model rewarded a moderate leverage level and adequate interest coverage, which together suggest the company can service its debt obligations, while the very large asset base reflects the scale of the enterprise.
Quarterly revenue was relatively stable across the last four reported periods (2025Q2: $111,616,000,000; 2025Q3: $113,161,000,000; 2025Q4: $113,215,000,000; 2026Q1: $111,721,000,000), but net income and operating income were highly volatile, collapsing to $10,000,000 and $380,000,000 respectively in 2025Q4 before rebounding sharply to $6,280,000,000 and $8,990,000,000 in 2026Q1.
The model reflected the mixed signal of steady revenues alongside severe earnings instability, with the dramatic 2025Q4 trough and subsequent 2026Q1 recovery creating an inconsistent earnings trend that limited the momentum score.
The dividend payout ratio in FY2025 was 15.9%, and dividends per share rose from FY2022's $6.40 through FY2023's $7.29 and FY2024's $8.18 before dropping sharply to $2.10 in FY2025.
The model recognized the multi-year history of dividend growth through FY2024 but likely discounted the score due to the significant decline in dividends per share in FY2025, while the low payout ratio suggests earnings coverage of the dividend remains conservative.
UnitedHealth Group is not currently assigned to any of the 24 tracked macro themes in the model.
The absence of a theme assignment means the security did not qualify for any thematic score contribution under the current methodology; this is a neutral classification rather than a negative signal about the company.
Research Summary
AI-generated analysis reflects data and conditions as of the report date shown above. Verify any specific figures through primary sources before acting on this analysis.
UnitedHealth Group posted strong top-line growth of +11.8% in FY2025, with revenue rising to $447,567,000,000, but this was overshadowed by a -16.3% decline in net income and a -14.7% drop in diluted EPS, reflecting meaningful earnings deterioration. Profitability margins remain thin at a 2.7% net margin and 4.2% operating margin, consistent with managed-care economics but constraining the overall score. Financial health is moderate, supported by a debt-to-equity ratio of 0.78 and interest coverage of 4.7, while quarterly earnings were highly volatile, including a near-total collapse in 2025Q4 before a sharp rebound in 2026Q1. The composite score of 40.7/100 reflects these mixed signals, earning a Monitor Only label with a Medium risk rating.
Plain English
UnitedHealth is bringing in more revenue than ever, but its profits dropped sharply last year, its quarterly earnings were all over the place, and its profit margins are very thin — so while the company is huge and financially stable enough, it's not firing on all cylinders right now.
Bull Case vs. Bear Case
Bull Case
- Revenue grew a solid +11.8% year-over-year to $447,567,000,000 in FY2025, demonstrating meaningful top-line expansion at scale.
- The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.78 and interest coverage of 4.7, suggesting the company can comfortably service its debt obligations.
- After a dramatic earnings trough in 2025Q4, operating income rebounded sharply to $8,990,000,000 in 2026Q1, hinting at potential earnings recovery.
Bear Case
- Net income fell -16.3% and diluted EPS dropped -14.7% in FY2025, meaning revenue growth did not translate into bottom-line improvement.
- Net margin of 2.7% and operating margin of 4.2% are very thin, leaving little buffer if costs rise or revenues soften.
- Dividends per share dropped sharply to $2.10 in FY2025 after reaching $8.18 in FY2024, a significant reversal of a multi-year growth trend.
What Could Change the Picture
Bullish Triggers
- A sustained recovery in quarterly net income and operating income above the 2026Q1 rebound level would signal that the 2025Q4 trough was an anomaly rather than a trend.
- Consistent improvement in net and operating margins beyond current thin levels would indicate the company is translating its large revenue base into stronger profitability.
Bearish Triggers
- A return to near-zero quarterly earnings similar to the 2025Q4 result of $10,000,000 net income would confirm that earnings instability is structural rather than temporary.
- Further declines in dividends per share beyond the already sharp FY2025 drop would signal deteriorating capital return capacity.
Risk Profile
Medium RiskUnitedHealth's interest coverage ratio of 4.7 and debt-to-equity of 0.78 suggest manageable financial obligations, but the extreme quarterly earnings volatility — with net income swinging from $3,406,000,000 in 2025Q2 to just $10,000,000 in 2025Q4 before rebounding to $6,280,000,000 in 2026Q1 — introduces meaningful uncertainty about the stability of future cash flows.
This report is for educational and research purposes only. It does not constitute financial, investment, legal, or tax advice — always conduct your own due diligence before making investment decisions.